Watch Demo

France Antidiabetics Industry Outlook 2024 - 2028

See how France Antidiabetics performed compared to key markets.

Key Market Indicators

**French Insulin Imports to Hit $1.13 Billion by 2028** Paris – French insulin imports are projected to reach approximately $1.13 billion by 2028, up from around $933 million in 2023. This growth represents a compound annual growth rate (CAGR) of 2.9%. The demand for insulin in France has seen a steady increase of 3.1% annually since 1999. **Export Forecasts Also Show Growth** On the export front, French insulin shipments are expected to climb to nearly $2.56 billion by 2028, rising from $2.31 billion in 2023. This marks an average annual growth rate of 1.5% over the period. Since 1999, the supply of insulin from France has grown by 1% each year. **Global Standing and Rankings** In 2023, France ranked as the second-largest exporter of insulin globally, with Germany leading at $2.31 billion. Italy and China followed France, securing the third and fourth positions, respectively.

Marketing Banner

France Antidiabetics Market Data and Forecasts

How much will France Antidiabetics Market grow to 2028?

Forecast: Export of Insulin in Dosage Forms from France
Forecast: Import of Insulin in Dosage Forms to France
Forecast: Import of Insulin to France
Forecast: Export of Insulin from France
Forecast: Export of Insulin in Dosage Forms from France
More in Antidiabetics Industry for 2028